Alfredo Martínez

31PUBLICATIONS
71CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)NanomedicineOptical technologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Aug 27, 2026
Proadrenomedullin N-Terminal 20 Peptide (PAMP) Increases Proliferation and Induces Cytoskeleton Remodeling in Melanoma Cells Through the CXCR7/CXCR4/β-Arrestin Axis.

|Jul 01, 2026
Optimized chemotherapy sequence for metastatic pancreatic ductal adenocarcinoma patients: FOLFIRINOX followed by Gemcitabine plus nab-paclitaxel.

|Mar 28, 2026
Downregulation of the Long Non-Coding RNA MDL1AS Alters Metabolism, Differentiation, and Radiosensitivity in NTERA2 and SH-SY5Y Cells.

Adrián Casas-Benito, Pablo Garrido, Alfredo Martínez

|Nov 13, 2025
A Stable RNA Vaccine Against the Regulatory Peptide Adrenomedullin Reduces Angiogenesis and Tumor Burden in a Subcutaneous Melanoma Model Without Inducing an Immunosuppressive Tumor Microenvironment.

Srdan Tadic, Josune García-Sanmartín, Judit Narro-Íñiguez

|Jul 17, 2025
Targeting Casein Kinase 2 and Histone Deacetylase with a Dual Inhibitor Effectively Reduces Tumor Growth in a Triple-Negative Breast Cancer Xenograft Model.

Irene Ortín, Laura Ochoa-Callejero, Christian Werner

|Jun 27, 2025
A DNA Vaccine Against Proadrenomedullin N-Terminal 20 Peptide (PAMP) Reduces Angiogenesis and Increases Lymphocyte and Macrophage Infiltration but Has No Effect on Tumor Burden in a Mouse Model of Lung Metastasis.

Tom Kalathil Raju, Srdan Tadic, Pablo Garrido

Pageof 6

Frequent Collaborators

14 joint publications

Josune García-Sanmartín

6 joint publications

Laura Ochoa-Callejero

6 joint publications

Pablo Garrido

4 joint publications

Judit Narro-Íñiguez